Novo's pill for kids; Altimmune’s $225M offering; Merck teams with Google Cloud

April 23, 2026 10:27 AM EDT News Briefing Novo's pill for kids; Al­tim­mune’s $225M of­fer­ing; Mer­ck teams with Google Cloud ENDPOINTS No­vo Nordisk’s GLP-1 pill works in kids with di­a­betes: Type 2 di­a­betes pa­tients aged 10 to 17 who took Ry­bel­sus for about six months had … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER